Contracts - Spark Newswire

1 minute read

Leidos Wins $13M Contract For CDC Bioinformatics, Computing Support Services

Today, 3:43 AM

Leidos (NYSE:LDOS), a Fortune 500® science and technology leader, was recently awarded a new prime contract by the Centers for Disease Control and Prevention (CDC) to provide bioinformatics and scientific

LDOS

2 minute read

HTG Molecular Diagnostics Receives First Commercial Orders For Planned HTG Transcriptome Panel, Signs 2 European Early Adopter Program Deals, No Terms Disclosed

By Benzinga Newsdesk

Today, 3:43 AM

HTG Molecular Diagnostics, Inc. (NASDAQ:HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced it has received the first commercial orders for its planned HTG Transcriptome

HTGM

1 minute read

Sanofi, Translate Bio Initiate Early-Stage mRNA Influenza Vaccine Trial

By Vandana Singh

Today, 3:43 AM

Sanofi Pasteur, vaccine unit of Sanofi SA (NASDAQ:SNY) and Translate Bio Inc (NASDAQ:TBIO) have initiated a Phase 1 trial evaluating an mRNA-based investigational vaccine…

SNY

1 minute read

GSK- Pfizer’s ViiV To Develop ‘Ultra-Long-Acting’ HIV Drugs With $215M Halozyme Deal

By Vandana Singh

Today, 3:43 AM

GlaxoSmithKline plc (NYSE:GSK), Pfizer Inc (NYSE:PFE), and Shionogi Limited owned ViiV Healthcare has collaborated with Halozyme Therapeutics Inc (NASDAQ:HALO) to gain access to Halozyme’s Enhanze drug delivery…

GSK

2 minute read

PLAYSTUDIOS, Acies Say Complete Business Combination, Will Begin Trading On Nasdaq As ‘MYPS’

By Benzinga Newsdesk

Today, 3:43 AM

PLAYSTUDIOS, Inc. ("PLAYSTUDIOS" or the "Company"), an award-winning developer of free-to-play casual mobile and social games that offer real-world rewards to loyal players, announced today that

ACAC

1 minute read

Cassava Sciences Says Selects Premier Research International For Phase 3 Clinical Program In Alzheimer’s Disease

By Benzinga Newsdesk

Today, 3:43 AM

Cassava Sciences, Inc. (NASDAQ:SAVA), a biotechnology company focused on Alzheimer's disease, today announced the selection of Premier Research International as its clinical research organization (CRO) to help

SAVA

2 minute read

Inhibrx Says Initiates Potential Registration-Enabling Phase 2 Study Of INBRX-109 In Conventional Chondrosarcoma Patients; Says Updates Data For Ongoing Phase 1 Study; Announces Amended Loan Agreement With Oxford

By Benzinga Newsdesk

Today, 3:43 AM

Inhibrx, Inc. (NASDAQ:INBX), a biotechnology company with four clinical programs in development, announced initiation of a potential registration-enabling Phase 2 study of INBRX-109 in conventional

INBX

2 minute read

Here’s Why Alset EHome International Gapped Past Resistance And Rallied

By Tyler Bundy

Today, 3:43 AM

Alset EHome International Inc. (NASDAQ: AEI) shares rallied higher Monday after the company announced a strategic agreement with Tesla Inc. (NASDAQ: TSLA) for an initial supply of Tesla PV solar chargers, Powerwalls, and

AEI

1 minute read

Alset EHome Partners With Tesla For PV Solar Panels

By Shivani Kumaresan

Today, 3:43 AM

Property developer Alset EHome International Inc (NASDAQ:AEI) has announced a partnership between its subsidiary, Alset EHome Inc, and Tesla Inc (NASDAQ:TSLA) for an initial…

AEI